top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pubbl/distr/stampa Washington, D.C., : National Academies Press, c2009
Descrizione fisica 1 online resource (99 p.)
Disciplina 616.075
Altri autori (Persone) GiffinRobert B
OlsonSteve <1956->
RobinsonSally
Soggetto topico Biochemical markers
Drugs - Safety measures
Drugs - Testing
Soggetto genere / forma Electronic books.
ISBN 1-282-27265-9
9786612272653
0-309-13125-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910454905103321
Washington, D.C., : National Academies Press, c2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pubbl/distr/stampa Washington, D.C., : National Academies Press, c2009
Descrizione fisica 1 online resource (99 p.)
Disciplina 616.075
Altri autori (Persone) GiffinRobert B
OlsonSteve <1956->
RobinsonSally
Soggetto topico Biochemical markers
Drugs - Safety measures
Drugs - Testing
ISBN 0-309-14231-8
1-282-27265-9
9786612272653
0-309-13125-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Overview Of key issues -- Cardiac safety biomarkers -- Assessing and predicting kidney safety -- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials -- Future considerations.
Record Nr. UNINA-9910778330203321
Washington, D.C., : National Academies Press, c2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academies Press, c2009
Descrizione fisica 1 online resource (99 p.)
Disciplina 616.075
Altri autori (Persone) GiffinRobert B
OlsonSteve <1956->
RobinsonSally
Soggetto topico Biochemical markers
Drugs - Safety measures
Drugs - Testing
ISBN 0-309-14231-8
1-282-27265-9
9786612272653
0-309-13125-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Overview Of key issues -- Cardiac safety biomarkers -- Assessing and predicting kidney safety -- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials -- Future considerations.
Record Nr. UNINA-9910828713903321
Washington, D.C., : National Academies Press, c2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug safety [[electronic resource] ] : FDA faces challenges overseeing the foreign drug manufacturing supply chain : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate / / statement of Marcia Crosse
Drug safety [[electronic resource] ] : FDA faces challenges overseeing the foreign drug manufacturing supply chain : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate / / statement of Marcia Crosse
Autore Crosse Marcia
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2011]
Descrizione fisica 1 online resource (15 pages)
Collana Testimony
Soggetto topico Drugs - Safety measures
Drugs - Safety measures - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug safety
Record Nr. UNINA-9910701237703321
Crosse Marcia  
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2011]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug safety [[electronic resource] ] : preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
Drug safety [[electronic resource] ] : preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
Autore Crosse Marcia
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008]
Descrizione fisica 19 pages : digital, PDF file
Collana Testimony
Soggetto topico Drugs - Safety measures
Drugs - Inspection
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug safety
Record Nr. UNINA-9910696615703321
Crosse Marcia  
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug safety [[electronic resource] ] : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
Drug safety [[electronic resource] ] : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
Autore Crosse Marcia
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007]
Descrizione fisica 24 pages : digital, PDF file
Collana Testimony
Soggetto topico Drugs - Safety measures
Drugs - Inspection
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug safety
Record Nr. UNINA-9910696397103321
Crosse Marcia  
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug safety [[electronic resource] ] : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
Drug safety [[electronic resource] ] : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
Autore Crosse Marcia
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007]
Descrizione fisica 13 pages : digital, PDF file
Collana Testimony
Soggetto topico Drugs - Safety measures
Drugs - Safety measures - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug safety
Record Nr. UNINA-9910695979303321
Crosse Marcia  
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug safety [[electronic resource] ] : better data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters
Drug safety [[electronic resource] ] : better data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008]
Descrizione fisica ii, 53 pages : digital, PDF file
Soggetto topico Drugs - Safety measures
Pharmaceutical industry - Foreign countries
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug safety
Record Nr. UNINA-9910697853703321
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrated cardiac safety [[electronic resource] ] : assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance / / J. Rick Turner, Todd A. Durham
Integrated cardiac safety [[electronic resource] ] : assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance / / J. Rick Turner, Todd A. Durham
Autore Turner J. Rick
Edizione [1st ed.]
Pubbl/distr/stampa Hoboken, N.J., : John Wiley & Sons, c2009
Descrizione fisica 1 online resource (500 p.)
Disciplina 616.1/23061
Altri autori (Persone) DurhamTodd A
Soggetto topico Cardiovascular toxicology
Heart - Effect of drugs on
Drugs - Side effects - Testing
Drugs - Safety measures
ISBN 1-282-00206-6
9786612002069
0-470-41129-5
0-470-41128-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety.
Record Nr. UNINA-9910144409203321
Turner J. Rick  
Hoboken, N.J., : John Wiley & Sons, c2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Las medicinas en la vejez [[electronic resource]]
Las medicinas en la vejez [[electronic resource]]
Pubbl/distr/stampa Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, , [2000]
Descrizione fisica 12 pages : digital, PDF file
Collana (FDA)
Soggetto topico Older people - Drug use - United States
Drugs - Overdose
Drugs - Safety measures
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione spa
Record Nr. UNINA-9910695326403321
Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, , [2000]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui